国产在线一区二区三区AV,国产AV天堂无码一区二区三区,黄色电影免费观看,国内精品久久久久久99蜜桃

Stock(600222)Hot line:010-61006450

MAH

Leader of "0" Cost MAH 3.0 Era

Platform Overview

Platform Overview
————???????—???????—???????—???????—???????—???????—

 
The project Initiation service platform has more than 20 professional knowledge personnel, all from Shenyang Pharmaceutical University, Chinese Academy of Medical Sciences, Peking Union Medical College and other well-known universities at home and abroad, and has set up generic drug project strategy center, clinical & pharmacology center, intellectual property center, big data analysis center, international new product strategy center, based on the all-round analysis of the pharmaceutical industry and combined with the company's own differentiated positioning, can provide customers with personalized information technology services and comprehensive information assurance.

 Service Content

—???????—???????—???????—???????—???????—???????—???????—???????—???????—

1) Generic Drug Project Initiation: Project development risk assessment is carried out through comprehensive analysis of listed product information, including review overview, patents, market prospects, competition pattern, technical barriers, policy dynamics and other mainstream regulatory countries in Europe, the United States, Japan, China, Canada, Australia and other mainstream regulatory countries.
???????

2)Improvement and Innovation Projects: According to the domestic clinical needs and the guidance of policies and regulations, look for potential improvement and innovation projects, conduct comprehensive research from the aspects of product clinical positioning, market value, competition dynamics, patent layout, and development and listing paths of such projects at home and abroad, determine the adequacy and feasibility of the basis for the topic, and conduct in-depth pharmaceutical technology evaluation, clinical evaluation, development cycle and cost evaluation of the proposed development project.
 

3) Strategy Consulting Service: According to the needs of enterprises, provide partners with product pipeline sustainable development planning, feasibility analysis of new entry fields, and R&D strategy formulation after policy changes, such as the development opportunities and challenges in the cardiovascular field, the key points of improved new drug technology research and development, the analysis of the clinical drug competition pattern of platforms (ophthalmic preparations, enteric-coatedpreparations, sustained-release preparations), and the monthly analysis report of CDE application acceptance products.
 

4)Patent Service: Patent layout of cooperation projects, patent risk assessment of new products, infringement analysis and circumvention strategies, patent search and analysis service, patent tracking and early warning analysis.

5)Resource sharing: The leadingpharm information department cooperates with many well-known pharmaceutical databases at home and abroad (cortellis, intranet, insight, wisdombud), which can provide domestic and foreign listing information, the latest information on industry policies, new products/targets at home and abroad, domestic and foreign product sales and forecast data, market access, clinical guidelines and clinical front-line drug consultation, etc.


 

 

 

 

 

 

 

久久久久亚洲精品中文字幕 | 国产激情一区二区三区app| 亚洲永久无码7777kkk| 色yeye香蕉凹凸一区二区-| 免费观看mv大片的直播软件| 欧美最猛性XXXXXX| 国外AV无码精品国产精品| 久久久久成人精品免费播放动漫| 日本无码欧美激情视频二区| 卡一卡2卡3卡精品网站| 欧美精品一区二区| 亚洲av无码成人精品区| 制服 小说 亚洲 欧美 校园| 久久久久亚洲精品中文字幕| 人妻熟妇乱又伦精品视频中文字幕| 性欧美丰满熟妇xxxx性久久久| 国产综合精品| 精品亚洲一区二区三区四区五区| 无码国产精品一区二区免费蜜桃 | 久久人妻av无码中文专区| 亚洲精品99久久久久中文字幕| 国产精品久久久久一区二区三区 | 久久精品无码一区二区三区免费| 国产69精品久久久久人妻刘玥 | 久久久国产精品VA麻豆| 国产午夜精品一区二区三区 | 色又黄又爽18禁免费视频| 寂寞少妇扒开双腿猛烈进入免费看| 97精品人人a片免费看| 无码少妇一区二区三区芒果| 永久免费不卡在线观看黄网站| 24小时在线看免费观看直播| 国产无套流白浆视频免费| 国产99久久久久久免费看| 亚洲一区精品无码色成人| 一夲道无码人妻精品一区二区| 色狠狠久久AV五月综合| 久久亚洲精品久久国产一区二区| 免费看国产曰批40分钟无码| 日本精品无码一区二区三区久久久| 永久免费av无码网站韩国毛片|